Citations (41)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Zhuo Wu, Ziran Li, Xiaoyan Qiu, Mingkang Zhong & Tianling Ding. (2023) Germline genetic variations in methotrexate pathway are associated with pharmacokinetics, outcome, and toxicity in patients with primary central nervous system lymphoma. Expert Review of Clinical Pharmacology 16:4, pages 371-381.
Read now
Read now
Toshiki Terao, Takafumi Tsushima, Daisuke Ikeda, Ami Fukumoto, Yuya Kamura, Ayumi Kuzume, Rikako Tabata, Daisuke Miura, Kentaro Narita, Masami Takeuchi & Kosei Matsue. (2022) Limited efficacy of high-dose methotrexate to prevent the central nervous system relapse in patients with IVLBCL. Leukemia & Lymphoma 63:14, pages 3394-3401.
Read now
Read now
Dan Xu, Shu-Ting Lu, Yu-Shuang Li, Aju Baidya, Hao Mei, Yong He & Bo Wu. (2018) Evaluation of methotrexate-conjugated gadolinium(III) for cancer diagnosis and treatment. Drug Design, Development and Therapy 12, pages 3301-3309.
Read now
Read now
Durrin Ozlem Dabak & Nevin Kocaman. (2015) Effects of silymarin on methotrexate-induced nephrotoxicity in rats. Renal Failure 37:4, pages 734-739.
Read now
Read now
Jori May, Kenneth R. Carson, Sara Butler, Weijian Liu, Nancy L. Bartlett & Nina D. Wagner-Johnston. (2014) High incidence of methotrexate associated renal toxicity in patients with lymphoma: a retrospective analysis. Leukemia & Lymphoma 55:6, pages 1345-1349.
Read now
Read now
Articles from other publishers (36)
Monteiro Joaquim Faria, Damas Rita, Bergantim Rui & Trigo Fernanda. (2023) Optimum Methotrexate Exposure in Patients With Suspected or Confirmed CNS Invasive Hematological Malignancies: A Systematic Critical Review. Therapeutic Drug Monitoring 45:3, pages 287-292.
Crossref
Crossref
Qiuyu Wu, Xiangjie Chen, Caixia Qiao, Xinhua Cao, Qian Du, Yukang Yuan, Yibo Zuo, Ying Miao, Zhijin Zheng, Tingting Zhang, Lichao Zang, Xinyu Yang, Weifeng Shi, Zhijun Xie, Yang Xu, Depei Wu, Chengping Wen & Hui Zheng. (2023) Methotrexate and Triptolide regulate Notch signaling pathway by targeting the Nedd4-Numb axis. International Immunopharmacology 114, pages 109595.
Crossref
Crossref
Shasanka Das, Bhausaheb Bagal, Hasmukh Jain, Lakhan Kashyap, Sekar Anbarasan, Sharma Abhishek, Suresh Bondili, Lingraj Nayak, Jayshree Thorat, Sumeet Mirgh, Anant Gokarn, Sachin Punatar, Sahay Ayushi, Sridhar Epari, Prashant Tembhare, Prakash Shetty, Nehal Khanna, Jayant Goda, Moiyadi Aliasgar, Tejpal Gupta, Manju Sengar, Navin Khattry, Siddhartha Laskar & Hari Menon. (2022) Demographics, Pattern of Care & Outcomes of Primary CNS Lymphoma- Experience from a Tertiary Care Cancer Center in India. Indian Journal of Hematology and Blood Transfusion 39:1, pages 57-70.
Crossref
Crossref
Tong Chen, Yuanbo Liu, Yang Wang, Qing Chang, Jinsong Wu, Zhiliang Wang, Daoying Geng, Jin-Tai Yu, Yuan Li, Xiao-Qiu Li, Hong Chen, Dongxiao Zhuang, Jianyong Li, Bin Wang, Tao Jiang, Lanting Lyu, Yuqin Song, Xiaoguang Qiu, Wenbin Li, Song Lin, Xinghu Zhang, Dehong Lu, Junqiang Lei, Yaolong Chen & Ying Mao. (2022) Evidence-based expert consensus on the management of primary central nervous system lymphoma in China. Journal of Hematology & Oncology 15:1.
Crossref
Crossref
Ruiqi Jiang, Shenghui Mei & Zhigang Zhao. (2022) Leucovorin (folinic acid) rescue for high‐dose methotrexate: A review. Journal of Clinical Pharmacy and Therapeutics.
Crossref
Crossref
Andrew B. DeAtkine, Moaaz Abdelrashid, Zach Tucker, Amitkumar Mehta, James M. Markert, Jinsuh Kim, John B. Fiveash, Robert A. Oster, Mina Lobbous & L. Burt Nabors. (2022) High-dose methotrexate and rituximab induction regimen in immunocompetent patients with primary CNS lymphoma: a retrospective single-center study of survival predictors. Journal of Neuro-Oncology 158:1, pages 33-40.
Crossref
Crossref
Giuseppe Pesenti, Marco Foppoli & Davide Manca. (2021) Optimal dose and uncertainty estimation for individualized drug administration using pharmacokinetic models. Computers & Chemical Engineering 153, pages 107421.
Crossref
Crossref
Giuseppe Pesenti, Marco Foppoli & Davide Manca. (2021) A minimal physiologically based pharmacokinetic model for high-dose methotrexate. Cancer Chemotherapy and Pharmacology 88:4, pages 595-606.
Crossref
Crossref
Jason N. Barreto, Kristen T. Peterson, Erin F. Barreto, Kristin C. Mara, Ross A. Dierkhising, Nelson Leung, Thomas E. Witzig & Carrie A. Thompson. (2021) Early, empiric high-dose leucovorin rescue in lymphoma patients treated with sequential doses of high-dose methotrexate. Supportive Care in Cancer 29:9, pages 5293-5301.
Crossref
Crossref
Elliot M. Frohman, Nicole R. Villemarette-Pittman, Adriana Rodriguez, Robert Glanzman, Sarah Rugheimer, Oleg Komogortsev, Scott S. Zamvil, Roberto Alejandro Cruz, Thomas C. Varkey, Ashley N. Frohman, Audrey R. Frohman, Matthew S. Parsons, Emily Heckmann Konkle & Teresa C. Frohman. (2021) Application of an evidence-based, out-patient treatment strategy for COVID-19: Multidisciplinary medical practice principles to prevent severe disease. Journal of the Neurological Sciences 426, pages 117463.
Crossref
Crossref
Catherine E. DeFino, Jason N. Barreto, Amanda G. Pawlenty, Michael W. Ruff, Ivan D. Carabenciov, Kristin C. Mara & Carrie A. Thompson. (2021) Lack of drug interaction between levetiracetam and high‐dose methotrexate in patients with lymphoma. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 41:5, pages 430-439.
Crossref
Crossref
Nadav Sarid, Felix Bokstein, Deborah T. Blumenthal, Ahuva Weiss-Meilik, Lili Gibstein, Irit Avivi, Chava Perry & Ron Ram. (2020) Impact of contemporary regimens on the outcomes and toxicity of primary CNS lymphoma: a single-center retrospective analysis of 73 patients. Journal of Neuro-Oncology 151:2, pages 211-220.
Crossref
Crossref
Elliot M. Frohman, Nicole R. Villemarette-Pittman, Roberto Alejandro Cruz, Reid Longmuir, Vernon Rowe, Elizabeth S. Rowe, Thomas C. Varkey, Lawrence Steinman, Scott S. Zamvil & Teresa C. Frohman. (2020) Part II. high-dose methotrexate with leucovorin rescue for severe COVID-19: An immune stabilization strategy for SARS-CoV-2 induced ‘PANIC’ attack. Journal of the Neurological Sciences 415, pages 116935.
Crossref
Crossref
Talal Hilal. (2020) Primary central nervous system lymphoma: Consensus, controversies, and future directions. ADVANCES IN CELL AND GENE THERAPY 3:3.
Crossref
Crossref
Uvette Lou, Jamie Kwok, Thu Anne Nguyen, Allen Zhou & Samantha O. Luk. (2019) Effect of Levetiracetam on Time to High‐Dose Methotrexate Clearance in Patients With Hematologic Malignancies. The Journal of Clinical Pharmacology 60:3, pages 324-330.
Crossref
Crossref
Abdulla Y. Al-Taher, Mohamed A. Morsy, Rehab A. Rifaai, Nagwa M. Zenhom & Seham A. Abdel-Gaber. (2020)
Paeonol Attenuates Methotrexate-Induced Cardiac Toxicity in Rats by Inhibiting Oxidative Stress and Suppressing TLR4-Induced NF-
κ
B Inflammatory Pathway
. Mediators of Inflammation 2020, pages 1-10.
Crossref
Crossref
Claire E. Knezevic & William Clarke. (2020) Cancer Chemotherapy: The Case for Therapeutic Drug Monitoring. Therapeutic Drug Monitoring 42:1, pages 6-19.
Crossref
Crossref
Giuseppe Pesenti, Marco Foppoli, Adriana Savoca & Davide Manca. 2020. 30th European Symposium on Computer Aided Process Engineering. 30th European Symposium on Computer Aided Process Engineering
709
714
.
Qingqing Cai, Yu Fang & Ken H. Young. (2019) Primary Central Nervous System Lymphoma: Molecular Pathogenesis and Advances in Treatment. Translational Oncology 12:3, pages 523-538.
Crossref
Crossref
Mukesh Patekar, Narayan Adhikari, Ahitagni Biswas, Vinod Raina, Lalit Kumar, Bidhu Kalyan Mohanti, Ajay Gogia, Atul Sharma, Atul Batra, Sameer Bakhshi, Ajay Garg, Sanjay Thulkar, Meher Chand Sharma, Sreenivas Vishnubhatla, Saphalta Baghmar & Ranjit Kumar Sahoo. (2019) Primary CNS Lymphoma in India: A 17-Year Experience From the All India Institute of Medical Sciences. Journal of Global Oncology:5, pages 1-9.
Crossref
Crossref
Ahmed Sagheir, Ayman Alhejazi, Mubarak Al-Mansour, Hani Alhashmi, Magdy Kandil, Ibraheem Motabi, Musa Alzahrani & Reyad Dada. (2019) Primary central nervous system lymphoma: Saudi Lymphoma Group's clinical practice guidelines for diagnosis, management and follow-up. Saudi Journal of Medicine and Medical Sciences 7:3, pages 219.
Crossref
Crossref
Jonathan Farhi, Kamel Laribi, Corentin Orvain, Jean-François Hamel, Mélanie Mercier, Aurélien Sutra Del Galy, Aline Clavert, Marie-Christine Rousselet, Aline Tanguy-Schmidt, Mathilde Hunault-Berger & Marie-Pierre Moles-Moreau. (2018) Impact of front line relative dose intensity for methotrexate and comorbidities in immunocompetent elderly patients with primary central nervous system lymphoma. Annals of Hematology 97:12, pages 2391-2401.
Crossref
Crossref
Biswajit Paul, Guillermo S. Romano Ibarra, Nicholas Hubbard, Teresa Einhaus, Alexander Astrakhan, David J. Rawlings, Hans-Peter Kiem & Christopher W. Peterson. (2018) Efficient Enrichment of Gene-Modified Primary T Cells via CCR5-Targeted Integration of Mutant Dihydrofolate Reductase. Molecular Therapy - Methods & Clinical Development 9, pages 347-357.
Crossref
Crossref
Shenghui Mei, Xingang Li, Xueyun Jiang, Kefu Yu, Song Lin & Zhigang Zhao. (2018) Population Pharmacokinetics of High-Dose Methotrexate in Patients With Primary Central Nervous System Lymphoma. Journal of Pharmaceutical Sciences 107:5, pages 1454-1460.
Crossref
Crossref
Xiao Han, Yali Ji, Mingqi Ouyang, Tienan Zhu & Daobin Zhou. (2017) Efficacy and safety of HD-MTX based systemic chemotherapy regimens: retrospective study of induction therapy for primary central nervous system lymphoma in Chinese. Scientific Reports 7:1.
Crossref
Crossref
Sarah A. Drost, Jason R. Wentzell, Pierre Giguère, Darcy L. McLurg, Mitchell Sabloff, Salmaan Kanji & Tiffany T. Nguyen. (2017) Outcomes Associated with Reducing the Urine Alkalinization Threshold in Patients Receiving High-Dose Methotrexate. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 37:6, pages 684-691.
Crossref
Crossref
Mariana N. Kerbauy, Fabio Y. Moraes, Benjamin H. Lok, Jennifer Ma, Lucila N. Kerbauy, Daniel E. Spratt, Fabio P.S. Santos, Guilherme F. Perini, Alejandro Berlin, Caroline Chung, Nelson Hamerschlak & Joachim Yahalom. (2017) Challenges and opportunities in primary CNS lymphoma: A systematic review. Radiotherapy and Oncology 122:3, pages 352-361.
Crossref
Crossref
Kento Umino, Shin-ichiro Fujiwara, Kazuya Sato, Daisuke Minakata, Hirofumi Nakano, Ryoko Yamasaki, Yasufumi Kawasaki, Miyuki Sugimoto, Chihiro Yamamoto, Kaoru Hatano, Kiyoshi Okazuka, Iekuni Oh, Ken Ohmine, Takahiro Suzuki, Kazuo Muroi & Yoshinobu Kanda. (2017) High-Dose Methotrexate and Cytarabine-Based Multi-Agent Chemotherapy (Modified Bonn Protocol) for Systemic Lymphoma with CNS Involvement. Acta Haematologica 137:2, pages 93-99.
Crossref
Crossref
Shin C. Beh, Eric Kildebeck, Ram Narayan, Allen Desena, Doug Schell, Elizabeth S. Rowe, Vernon Rowe, Dennis Burns, Louis Whitworth, Teresa C. Frohman, Benjamin Greenberg & Elliot M. Frohman. (2017) High-dose methotrexate with leucovorin rescue: For monumentally severe CNS inflammatory syndromes. Journal of the Neurological Sciences 372, pages 187-195.
Crossref
Crossref
A. Aldaz & P. Schaiquevich. 2017. Individualized Drug Therapy for Patients. Individualized Drug Therapy for Patients
281
306
.
Orianne Olivares, J. Henry M. Däbritz, Ayala King, Eyal Gottlieb & Christina Halsey. (2015) Research into cancer metabolomics: Towards a clinical metamorphosis. Seminars in Cell & Developmental Biology 43, pages 52-64.
Crossref
Crossref
C Y Cheah, K E Herbert, K O'Rourke, G A Kennedy, A George, P L Fedele, M Gilbertson, S Y Tan, D S Ritchie, S S Opat, H M Prince, M Dickinson, K Burbury, M Wolf, E H Januszewicz, C S Tam, D A Westerman, D A Carney, S J Harrison & J F Seymour. (2014) A multicentre retrospective comparison of central nervous system prophylaxis strategies among patients with high-risk diffuse large B-cell lymphoma. British Journal of Cancer 111:6, pages 1072-1079.
Crossref
Crossref
Elizabeth H. Phillips, Christopher P. Fox & Kate Cwynarski. (2014) Primary CNS Lymphoma. Current Hematologic Malignancy Reports 9:3, pages 243-253.
Crossref
Crossref
Carole Soussain, Caroline Houillier, Sylvain Choquet & Khê Hoang-Xuan. (2014) Actualités des lymphomes cérébraux primitifs (LCP). Bulletin du Cancer 101:3, pages 314-324.
Crossref
Crossref
Tobias Birnbaum, Katja Bochmann, Louisa von Baumgarten & Andreas Straube. (2013) Early relapses in patients with primary CNS lymphoma treated with methotrexate-based chemotherapy without consolidating whole brain irradiation. Journal of Neuro-Oncology 112:2, pages 233-239.
Crossref
Crossref
Amy M. Wockenfus, Christopher D. Koch, Patricia M. Conlon, Linda D. Sorensen, Kari L. Cambern, Amy J. Chihak, Julie A. Zmolek, Amy E. Petersen, Bradley E. Burns, John C. Lieske & Brad S. Karon. (2013) Discordance between urine pH measured by dipstick and pH meter: Implications for methotrexate administration protocols. Clinical Biochemistry 46:1-2, pages 152-154.
Crossref
Crossref